Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06130540
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2023-11-08
Brief Title:
Study to Evaluate the Pharmacokinetics Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis